Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy
J Thorac Dis
.
2019 Nov;11(11):4400-4403.
doi: 10.21037/jtd.2019.10.67.
Authors
Chiara Lazzari
1
,
Vanesa Gregorc
1
,
Mariacarmela Santarpia
2
Affiliations
1
Division of Experimental Medicine, IRCCS San Raffaele Scientific Institute, Milano, Italy.
2
Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy.
PMID:
31903227
PMCID:
PMC6940227
DOI:
10.21037/jtd.2019.10.67
No abstract available
Publication types
Editorial
Comment